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INTRODUCTION 
One of the significant demographic changes noticed both in the 
developed and developing countries is the gradual increase in the ageing 
population
 (1)
.
 
The average lifespan of a women in India is 65 years while in 
developed countries it is 80 years, so women of our country deserve special 
attention
(2)
. A women, gradually transcends into perimenopause and after a 
couple of years into menopause in her reproductive period
 (3)
.
 
Perimenopause  includes the period beginning  with the first clinical, 
biological and endocrinological features of the approaching menopause such as 
vasomotor symptoms, menstrual irregularities and ends 12 months after the 
final menstrual period
(2)
. It refers to the time period in the late reproductive 
years usually late forty’s to early fifty’s. 
Menopause, consists of gradual transition from reproductive to the non-
reproductive phase of life, which is  a normal ageing phenomenon in 
women
(4)
.The term menopause  refers to a point in time that follows one year 
after the cessation of menstruation
(5)
.  The postmenopause describes those years 
following this point and this occurs between the age group of 45 and 60. 
Menopause is an example of endocrinal senescence. It is a normal 
biological event and it signifies the depletion of functional ovarian follicles that 
are responsible for estradiol production. Metabolic and physiological functions 
within the women’s body are affected due to hormonal deficiency including the 
cardiovascular system
 (6)
. 
With the advancement of age and menopausal duration, there are also 
changes in functions of different organs of the body and responses of the 
autonomic nervous system. 
Menopause transition is the period before the final menstrual period 
when variability occurs in the menstrual cycles. Vasomotor symptoms like hot 
flushes and night sweats are the common clinical symptoms during this 
transition period. These symptoms suggest an alteration of either local control 
of blood flow to skin or the cardiovascular reflexes, which is due to alteration 
of autonomic hemodynamic control. 
In our country, postmenopausal women are at risk of developing 
cardiovascular disease associated with autonomic nerve dysfunctions 
(7)
. 
During menopausal period, alterations in autonomic nerve functions may occur 
and it commonly affects cardiac vagal control which is associated with 
sympathetic over activity
 (8)
. Recent attention on postmenopausal health has led 
to study the autonomic function status in postmenopausal women and the 
relationships of decreased level of estrogen with autonomic nerve 
dysfunction
(9)
.
 
Thus, this study was done to compare the autonomic functions in 
perimenopausal and postmenopausal women to assess any significant 
deviations in sympathetic and parasympathetic activity and also to test the 
estrogen role in the modulation of autonomic functions. 
  
 
 
 
 
 
 
 AIMS   AND   OBJECTIVES 
1. The study   is   to compare   the    autonomic functions in perimenopausal 
women with the postmenopausal women. 
2.  To   test   the   hypothesis   that   estrogen   exerts   regulatory   influence on 
autonomic nervous system in postmenopausal women. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
                                     REVIEW OF LITERATURE 
                          The term menopause is derived from the Greek menos 
(months) and pausos (ending). An average Indian woman now lives up to 65 
years of age, whereas in developed countries, a lifespan up to 80 years is 
possible with the consequence that a woman spends one third of her life after 
menopause and possess health problems. The health problems cropping during 
this period are related to estrogen deficiency
 (10)
. 
DEFINITIONS:  
Premenopause:  
              It refers to the entire reproductive period from menarche to the final 
menstrual period. 
Perimenopause:  
               Includes the period beginning with the first clinical, biological and 
endocrinological features of the approaching menopause such as vasomotor 
symptoms and menstrual irregularity and ends 12 months after the final 
menstrual period. 
 Menopause:   
             The   permanent cessation  of  menstruation  at  the  end of  
reproductive  life due  to  loss of ovarian follicular activity and is recognized to 
have occurred after 12 consecutive months of amenorrhea, for which no 
pathological  cause  should be present. 
Postmenopause:  
         This is from the final menstrual period, regardless of whether the 
menopause was induced or spontaneous.  
       Progressive loss of ovarian follicular units occurs throughout life. 
Approximately 6 to 7 million germ cells are present in the two ovaries of the 
developing female fetus at 20 weeks gestation. At birth, only 1 to 2 million 
follicular units remains in the ovaries. A more rapid depletion of follicles starts 
in the late 30’s and early 40’s and continues until a point at which the 
menopausal ovary is virtually devoid of follicles
(5)
. The process of atresia of the 
non-dominant cohort of follicles, largely independent of menstrual cyclicity, is 
the prime event that leads to the eventual loss of ovarian activity and 
menopause. 
HYPOTHALAMUS –PITUITARY-OVARIAN-AXIS : 
                     Gonadotrophin   releasing   hormone is released   by the arcuate 
nucleus of the hypothalamus in a pulsatile manner, during the reproductive 
period. It binds with GnRH receptors on the pituitary to stimulate the 
luteinizing hormone and follicle stimulating hormone to release. And in turn, it 
also stimulates the production of the ovarian steroids: estrogen, progesterone 
and also inhibin.  Estrogen and progesterone exerts positive and negative 
feedback on gonadotrophin secretion. 
            The loss of functional ovarian follicles during menopause, leads to the 
decreased production of estrogen which reduces the negative feedback to the 
anterior pituitary, in turn leads to increased level of FSH. Diminished inhibin 
production by the ageing ovary may also contribute to the sharp rise in the 
FSH, a level that occurs in the perimenopausal period of life. During 
menopause, anterior pituitary still secretes FSH and LH in pulses, presumably 
after cyclic release of GnRH from the hypothalamus
 (10)
. 
MENOPAUSAL SYMPTOMS:  
                      Effects can range from discomfort to long term changes that can 
have a profound effect on a women’s health. 
Short term effects: 
Amenorrhea:  
            Amenorrhea is defined as absence of menstruation for more than ninety 
days in a woman with the regular menstrual cycles. 
Hot flushes:  
                 The symptom associated with estrogen deficiency is the hot flush, 
also known as hot flash. This symptom is described as “recurrent, transient 
periods of flushing, sweating and a sensation of heat, often accompanied by 
palpitations, feelings of anxiety and sometimes followed by chills. 
            This change is particularly marked in the fingers and toes, where skin 
temperature can increase 10
o
C to 15
o
C. Heart rate and skin blood flow peaks 
within 3 minutes of the onset of the hot flush.  
           Physiologically, hot flushes are due to increase in the frequency and 
intensity of the GnRH pulses from the hypothalamus.  Some neurotransmitters 
also play a role on hot flushes, e.g., nor-epinephrine, serotonin, dopamine, β 
endorphin
 (11, 12)
. 
Sleep disturbances and fatigue:  
               Sleep disruption is a common complaint of women with hot flushes. 
Disturbed sleep can lead to fatigue, irritability, depressive symptoms, cognitive 
dysfunction and impairment in daily functioning. Associated somatic 
symptoms are headache, joint pain. 
Long term effects:  
               Low estrogen levels have a cumulative effect on many tissues.   
Prolonged estrogen deficiency may contribute to the development of life 
threatening and irreversible conditions such as cardiovascular disease and 
osteoporosis
 (11)
.  
ESTROGEN:  
                Estrogens are secreted in sufficient quantities by the theca interna and 
granulosa cells of the ovarian follicles, in the non pregnant female.  Minute 
quantities are also secreted by the adrenal cortices. The principal estrogen 
secreted by the ovaries is beta estradiol 
(13)
. 
                    Estrogen is a steroid hormone, synthesized from cholesterol 
derived from blood and to a slight extent from acetyl co-enzyme A. During 
synthesis progesterone and testosterone are synthesized first and then these are 
converted into estrogens. This reaction is stimulated by Gonadotrophin. 
Estrogen was chemically synthesized in the 1920s.In 1935, Mazer and Israel 
was the first one to report, the successful treatment for the menopausal women, 
who complained of vasomotor symptoms with estrogen 
(12)
.
 
 
Analysis of Estrogen: 
Method: CLIA – Chemiluminescence immunoassay 
          A Chemiluminescence reaction is a chemical reaction in which one of 
the products of the reaction is light. The enzyme peroxidase can react with 
molecules such as luminal to yield light as part of the reaction product 
(14)
 .
 
               The advantage of this technique is that it can be very sensitive. This 
method is capable of measuring low concentrations of estradiol in 
postmenopausal women
 (15)
. 
NORMAL VALUES OF ESTROGEN DURING 
(16) 
Premenopause       :             40-400µg/ml 
           Perimenopausal : 120-160µg/ml 
Menopause  : 10-20µg/ml 
 
 
 
EFFECTS OF ESTROGEN ON AUTONOMIC FUNCTION: 
                      Menopausal cause is due to ‘burning out’ of the ovaries, which 
results in the reduction of estrogen. 
                   Menopause causes an increase in sympathetic activation due to 
endothelial dysfunction. Sympathetic activation may result in increased release 
of renin and angiotensin II. Endothelial dysfunction also causes reduction in 
Nitric oxide and increase in endothelin. Thus, there is increase in levels of 
vasoconstrictors (angiotensin II, endothelin) and a reduction in nitric oxide 
during menopause. 
                     Estrogens, by inhibiting the angiotensin II production would 
increase the effects of nitric oxide. They also increase the production of 
prostacycline; endothelium derived hyperpolarizing factor and nitric oxide 
release and inhibits the degradation of bradykinin by ACE inhibition. Thus, 
there is a balance between the effects of angiotensin and nitric oxide which, 
plays an important role in the regulation of vascular tone 
(17)
.
 
                  Estrogens also modulate sympathetic control of smooth muscle 
function. It inhibits the atherosclerotic plaque formation. Catechol estrogens 
are formed in the central nervous system and are present at significant levels in 
the pituitary and hypothalamus. They may serve as neurotransmitters and 
interact with adrenergic as well as steroid receptors. It also inhibits 
proliferation of smooth muscle cells 
(18)
. 
                   Sympathetic and Parasympathetic system controls the 
cardiovascular function and the risk of cardiovascular disease was enhanced by 
abnormal autonomic activity.  Several studies also showed    that the 
cardiovascular function is modulated by estrogen.      
            Through feedback inhibition, estrogen was found to inhibit the activity 
of tyrosine hydroxylase, which is a rate limiting enzyme in catecholamine 
synthesis 
             During sympathetic nerve activation, release of nor-adrenaline is 
modulated by presynaptic control mechanisms. The feedback inhibition, which 
was mediated by nor-adrenaline stimulation of presynaptic α2 adrenoceptors, is 
the most important one. Estrogen also increases the density and promotes the 
function of α2 adrenoceptors. The reduction in maximum levels of heart rate 
and systolic blood pressure was due to decrease in catecholamine response by 
estrogen 
(19) 
. 
                 In the central nervous system, estrogen potentiates 
cholinomuscarinic activity.  Choline uptake is facilitated by estrogen due to 
high affinity uptake systems. Estrogen is responsible for the neural 
development and its functions. These types of neuronal actions of estrogen are 
also reported in other neurotransmitters including Dopamine, Serotonin, and 
Nitric oxide.  Estrogens also affects the synthesis and actions of   angiotensin II 
and Nitric oxide in the central nervous system and cardiovascular system, 
which exerts indirect modulation on autonomic neurotransmission. 
AUTONOMIC NERVOUS SYSTEM: 
HISTORY:                   
                      During the Roman period, Galen described about the sympathetic 
ganglion and the rami communicantes. He said that this ganglion was 
originated in the central nervous system (brain). The ganglion chain arised and 
descended from the brain especially from posterior fossa, which was 
hypothesized by Thomas Willis in 1664. It was associated with the involuntary 
action. During 1732, Winslow introduced the new term sympathetic nerve. 
Lastly, in the 19th century Walter Gaskell concluded that autonomic nervous 
system was consisted of two subdivisions. During   this   century further 
refinements were contributed by ThomasElliot, Walter Dixon and Otto 
Leewi
(20)
. 
                     The Autonomic nervous system is the part of the nervous system 
that is responsible for homeostasis. The word autonomic is derived from the 
Greek word the auto means “self” and nomos means “control.” It is also called 
vegetative system, because it controls the vegetative functions. This system 
helps to control arterial pressure, gastrointestinal secretion, and gastrointestinal 
motility, emptying of urinary bladder, sweating, body temperature, and also 
other activities. One of the most important features of autonomic nervous 
system is the rapidity and intensity by which it can change visceral functions.  
Within 3 to 5 seconds it can increase the heart rate to twice the normal and 
within 10 to 15 seconds the arterial pressure can be doubled or it can be 
decreased low enough within 10 to 15 seconds to cause fainting 
(21)
. 
ANATOMY AND PHYSIOLOGY OF AUTONOMIC NERVOUS   SYSTEM: 
                  Autonomic nervous system has two main physiological as well as 
anatomical divisions, sympathetic and parasympathetic, each having a central 
and peripheral component. 
 
SYMPATHETIC NERVOUS SYSTEM: 
                Sympathetic division also called thoracolumbar division consists of 
thoracic and lumbar chains of sympathetic ganglia. 
Preganglionic neurons: 
                        The cell bodies of sympathetic Preganglionic neurons are found 
in the intermediolateral horn of the spinal cord from level T1 to L2. Hence 
sympathetic division is   also known as thoracolumbar outflow of autonomic 
nervous system. From the spinal cord  the  axons of visceral  motor  neurons 
leave,  via  ventral root and then travel through  the white  rami  
communicantes to the paravertebral  ganglia of the sympathetic trunk
(22)
.  
             Some fibers may go up or down in the sympathetic trunk to terminate 
in the ganglia located at a higher or lower level. Other fibers may travel 
through the sympathetic trunk and exit without synapsing via splanchnic nerve 
and terminate in a prevertebral ganglion. 
 
 
Sympathetic ganglia: 
Sympathetic ganglia are of two types: 
1. Paravertebral ganglia  
2. Prevertebral or collateral ganglia 
3. Peripheral or terminal ganglia 
Paravertebral ganglia: 
                        Paravertebral ganglia are arranged as enlargement along the 
entire length of two sympathetic trunks. They are divided into: 
Cervical ganglia: These are three in number – superior, middle and inferior. 
Thoracic ganglia: These are 11-12 in number 
Lumbar ganglia: are 4 in number 
Prevertebral ganglia: 
                     Are three in number- celiac ganglion, inferior mesenteric 
ganglion, and superior mesenteric ganglion. 
Peripheral ganglia: 
                      Are located within or close to structures innervated by them. 
Heart, bronchi, pancreas, and urinary bladder are innervated by the terminal 
ganglia. 
 
Postganglionic neurons: 
                     Sympathetic postganglionic neurons are located primarily in  
ganglia on the sympathetic trunks. The axons may pass through a grey ramus 
communicantes and re-enter ventral root to reach a spinal nerve. These fibers 
are unmyelinated. 
Sympathetic afferent fibers:  
                The afferent myelinated fibres from the viscera pass through the 
sympathetic ganglia without synapsing anywhere. These fibers enter the spinal 
nerve via the white rami communicantes. It reaches their cell bodies in the 
posterior root ganglia of the spinal nerve. After entering the spinal cord, it 
forms the afferent limb of the local reflex arc. Some also travel up to higher 
autonomic centers in the brain 
(22)
.  
 
PARASYMPATHETIC NERVOUS SYSTEM: 
                          The parasympathetic fibers form the craniosacral outflow, 
consisting of cranial parasympathetic outflow and sacral parasympathetic 
outflow. 
Cranial component:  
                       Cell bodies of Preganglionic neurons of cranial component of 
parasympathetic system are located in the brainstem. Brainstem 
parasympathetic neurons innervate structures in the head, neck, thorax and 
abdomen. Parasympathetic axons from brainstem travel in III, VII, IX and X. 
Nuclei of the cranial nerves are present in the midbrain in tectum, Pons and 
medulla. Therefore, these nuclei serve as the centers for the integration of 
autonomic reflexes for the organ systems they innervate. 
Sacral component: 
                    Sacral parasympathetic neurons innervate structures in the pelvis. 
Preganglionic neurons: 
                  Cell bodies are found in the intermediolateral grey horn of sacral 
segments S2, S3, S4 of spinal cord. Their axons form, Preganglionic fibers 
which pass out through the ventral spinal root of corresponding nerves. After 
leaving from the spinal nerves, it forms pelvic splanchnic nerves, which finally 
ends in pelvic autonomic plexus. 
Postganglionic neurons: 
                    These neurons are located in the pelvic autonomic plexuses close 
to or within the viscera. Their axons run a very short course to supply the 
concerned pelvic viscera.    The ratio of Preganglionic fibers to postganglionic 
fibers is 1:1.  
               Thus, the action of the parasympathetic system were found to be more 
discrete and localized. But, in sympathetic system there is a diffuse discharge.  
These fibers also supply the rectum, the sigmoid colon, the descending colon 
and the left one- third of transverse colon
 (21, 22)
. 
Parasympathetic afferent fibers: 
 
               The afferent fibers pass from viscera to their cell bodies found in the 
sensory ganglia of the cranial nerves or in sacrospinal nerves (posterior root). 
The central axons then take part in formation of local reflex arc, or it may also 
travel to higher centers of the autonomic nervous system. 
     
         
 
 
 
 
 
 
 
 
 
 
      
Distinguishing Features of the Sympathetic and Parasympathetic Systems 
Sympathetic system Parasympathetic System 
Originates in thoracic and lumbar 
regions of the spinal cord.(T1-L2) 
Originates in brainstem (cranial nerves 
III,VII,IX,X)and sacral region of 
spinal cord.(S2-S4) 
Ganglia are found in paravertebral 
sympathetic ganglion. 
Terminal ganglia are merged within  
the target tissue  
Ratio of Preganglionic fibers to 
postganglionic fibers is 1:20 
Ratio of Preganglionic fibers to 
postganglionic fibers is 1:3 
 Cholinergic Preganglionic fibres are 
short; Adrenergic postganglionic 
fibres are long 
 Cholinergic Preganglionic fibres are 
long; cholinergic postganglionic fibres 
are short. 
 More divergence that coordinates the 
activity of neurons in the spinal cord.  
Less divergence 
Nor-epinephrine is the 
neurotransmitter of postganglionic 
neurons. 
Acetylcholine is the neurotransmitter 
of postganglionic neurons. 
Predominant action is during 
emergency, “fight or flight “reactions 
and exercise 
The action is present during quiet 
resting conditions 
 
 
 
 
HIGHER CONTROL OF AUTONOMIC NERVOUS SYSTEM: 
                 The hypothalamus has a controlling influence on the autonomic 
nervous system and appears to integrate the autonomic neuroendocrine 
systems, thus preserving body homeostasis. Essentially the hypothalamus 
should be regarded as a higher nervous centre for the control of lower 
autonomic centers in the brainstem and spinal cord. For its major role in 
autonomic functions, hypothalamus was designated as “Head ganglion of the 
autonomic nervous system”. 
                Stimulation of hypothalamus (anterior part) can influence 
parasympathetic responses, whereas stimulation of the posterior part of the 
hypothalamus gives rise to sympathetic responses. In addition lower brain stem 
centers such as vasopressor, vasodilator, cardioaccelarator and respiratory 
centre has been found in the reticular formation. The neurons of the 
thoracolumbar outflow of the sympathetic part of the system and neurons of the 
craniosacral outflow of the parasympathetic part of the system receive their 
control through the descending tracts of the reticular formation 
(23)
. 
               These control centres, present in the brainstem and hypothalamus are 
highly influenced by higher brain areas. The cerebral cortex and the limbic 
system also influence the autonomic nervous system activities along with 
emotional responses by way of hypothalamic-brainstem pathways. For 
example, blushing during an embarrassing moment, this originates in the 
frontal association cortex, results in vasodilatation of blood vessels to the face. 
Other emotional responses like breaking out in a cold sweat, a racing heart rate 
were also influenced by these higher brain areas. 
 
                  At the level of spinal cord few autonomic reflexes were also 
processed. They are defecation and micturition reflex. These reflexes also 
occur without input from the brain even though they are influenced from 
higher nervous centres.            
 
                                   Figure No: 1 Higher control of the ANS 
 
Neurotransmitters of the Autonomic Nervous System: 
             The sympathetic and parasympathetic nerve fibres secrete mainly one 
or the other of two synaptic transmitter substances, Acetylcholine or Nor-
epinephrine. Neurotransmitters are produced in the axon varicosities and are 
stored in vesicles and released whenever needed. Those fibres that secrete 
acetylcholine are said to be cholinergic. Those that secrete nor-epinephrine are 
said to be adrenergic, a term derived from adrenalin, which is an alternate name 
for epinephrine. All Preganglionic neurons are cholinergic in both sympathetic 
and parasympathetic nervous system. Either all or almost all of the 
postganglionic neurons of the parasympathetic system are also cholinergic. 
Conversely, most of the postganglionic sympathetic neurons are adrenergic
 (23)
.  
      The cells of the adrenal medulla are considered to be the modified 
sympathetic postganglionic neurons. They release hormones into the blood.  
The hormonal output of the adrenal medulla is nearly 20% mainly the nor-
epinephrine. The epinephrine is 80%. The adrenal medulla contains an enzyme 
that converts nor-epinephrine to form epinephrine. The formation of 
epinephrine, which is also known as adrenaline, is produced during stress. 
These two hormones are called as catecholamines that are released by the 
adrenal medulla. However, the postganglionic sympathetic nerve fibres to the 
sweat glands, to the piloerector muscles of the hairs and to a very few blood 
vessels are cholinergic. 
              The terminal nerve endings of the parasympathetic system secrete 
acetylcholine. Almost all of the sympathetic nerve endings secrete nor-
epinephrine, but a few secrete acetylcholine. Therefore, acetylcholine is called 
a parasympathetic transmitter and nor-epinephrine is called a sympathetic 
transmitter 
(20-24)
. 
 
Termination of Neurotransmitter activity: 
                    Termination is necessary to allow new signals and influence 
effector tissue function. The first and foremost mechanism done by the 
cholinergic synapses is enzymatic degradation. Choline and acetate are the two 
products that are formed due to the hydroxylation of acetylcholine by 
acetylcholinesterase. Thus, acetyl cholinesterase is the fastest acting enzymes 
in our body and removal of acetylcholine occurs in less than 1 msec.  
              The reuptake of nor-epinephrine into the sympathetic nerve, that 
releases is the most significant mechanism for the removal of nor-epinephrine 
from the neuro-effector junction. Nor-epinephrine is metabolized intraneurally 
by Monoamine oxidase.  Catechol-O-methyltransferase enzyme inactivates the 
circulating catecholamine like epinephrine and nor-epinephrine in the liver 
(23)
. 
FUNCTIONS OF THE AUTONOMIC NERVOUS SYSTEM:  
Sympathetic nervous system:               
             It is designed for quick, immediate and massive action and in 
conjunction with the adrenal medulla initiate reactions in conditions of stress. 
The sympathetic-adrenal axis comes into play in conditions of emergencies and 
threatened danger causing fright, flight or fight.  The sympathetic system that 
elicits the “fight or flight” reaction is a whole body response (25). 
1.  Cardiac output is increased due to increase in the heart rate and myocardial 
contractility. 
2. Sympathetic activation of vascular smooth muscle causes vasoconstriction, 
mostly in kidneys and gastrointestinal organs. It helps to divert the blood 
towards the contracting muscles. 
3. The movement of air inside and outside of the lungs is facilitated by 
bronchodilatation. Thus, the oxygen uptake from the atmosphere and the 
carbon dioxide elimination from the body are enhanced. 
4.  The concentration of glucose in the blood is increased by glycogenolysis 
and gluconeogenesis in the liver. 
5. The fatty acid substances in the blood are increased by lipolysis in adipose 
tissue. For contraction, skeletal muscle utilizes these fatty acids to form 
metabolic energy. During the conditions of increased physical exertion, 
sweating is caused by the sympathetic activity that makes the individual to 
thermo regulate. 
6. The lens adapts for distance vision by dilating the pupil and allowing more 
light to enter the retina. 
           Each Preganglionic fibre arborizes with a large number of ganglia, thus 
enabling a simultaneous massive reaction to be set in motion as a result of a 
single command. The cardiovascular, respiratory, glycogenolytic and other 
actions enable to meet the threatened dangers. This type of sympathetic activity 
involves expenditure of energy and is called “Catabolic division of autonomic 
nervous system” (23, 25). 
Parasympathetic nervous system: 
                   It has long preganglionic fibres like that of the vagus and each 
ganglion has connections with only limited number of postganglionic fibres, so 
that the action is individualized and discrete. 
1. It decreases the heart rate that helps to conserve energy.  
2.  The swallowing of food is enhanced by salivary secretion. 
3. Gastric, intestinal motility and secretion are stimulated to favour the 
absorption of nutrients. 
4. Exocrine and endocrine secretion from the pancreas is promoted and thus 
contributes to the chemical breakdown of the food in the intestine. Storage of 
nutrient substances in the tissues are promoted by the release of insulin from 
the Islet’s of pancreas. 
5. Contraction of urinary bladder results in urination. 
6. Pupil is constricted and the lens adapts for near vision.     
 Thus, it regulates the secretor activity of the salivary, gastrointestinal and other 
glands, motor activity of the gastrointestinal and urinary bladder smooth   
muscle activity  and it’s action  restore’s  body energy reserve. It favours 
digestion, absorption and thus referred to as “anabolic nervous system” (25). 
AUTONOMIC RECEPTORS: 
            The autonomic neurotransmitters (Acetylcholine and Nor-epinephrine) 
produce their effects on the organs by combining with specific protein 
molecules known as receptors. 
I.  Cholinergic receptors: 
     a. Nicotinic receptors 
     b. Muscarinic receptors 
Nicotinic receptors: 
Location:   These receptors are located at   
 1. Autonomic ganglia- Transmission is mediated by N2 nicotinic receptors. 
They are blocked by hexamethonium. 
2. Neuromuscular junction- Transmission is mediated by N1 nicotinic 
receptors. They are blocked by atropine. 
3. Adrenal medulla 
 
Activation: are activated by 
a. Acetylcholine 
b. Nicotine 
Effects:  Produce excitation 
Muscarinic Receptors: 
Location: Are located in 
1. Heart 
2. Smooth muscles (except vascular smooth muscle) 
3. Glands 
Activation by: 
a. Acetylcholine  
b. Muscarine 
Effects: 
1. Inhibitory in the heart 
2. Excitatory in smooth muscles and glands 
Adrenergic receptors: 
           On the basis of their pharmacologic properties, adrenergic receptors are 
of two types. 
1. Alpha adrenergic receptors (α1, α2) 
2. Beta adrenergic receptors (β1, β2, β3) 
Alpha1 receptor:  
 These receptors are located in smooth muscle of skin, Gastrointestinal and 
bladder sphincters, Radial muscle of iris. 
Effects: These receptors produce excitation. 
Alpha2 receptors:  
 These receptors are located in presynaptic terminals, platelets, fat cells, walls 
of the gastrointestinal tract. 
Effects: Often produce inhibition 
Beta1 receptors: Located in SA node, AV node, Ventricular muscle of the 
heart. 
Effects: Produce excitation 
Beta2 receptors: located in vascular smooth muscle of skeletal muscle, 
Bronchial smooth muscle, wall of the GI tract, Bladder. 
Effects: Produce relaxation 
Beta3 receptors: Located in adipose tissue. 
Effects:  Lipolysis 
(22-25)
 
 
Physiological effects of Autonomic nervous system: 
Cardiovascular system:  
               The heart is innervated by parasympathetic and sympathetic neurons. 
The cell bodies of parasympathetic Preganglionic neurons that innervate the 
heart are found in the medulla. 
                The sympathetic innervation of the heart is from neurons in the 
intermediolateral columns at the T1-T4 levels. Axons of these neurons mainly 
synapse with the superior, middle, and inferior cervical ganglia that are the 
origin of postganglionic sympathetic neurons. These axons innervate the 
sinuatrial and atrioventricular nodes. The conduction system and myocardial 
muscle fibres in the ventricles was also innervated by sympathetic neurons. In 
systemic circulation, the arteries and veins are mostly innervated by 
sympathetic neurons
 (20)
.  
       Postganglionic parasympathetic neurons release acetylcholine. It activates 
muscarinic receptors found in the heart, that causes reduction in heart rate and   
conduction. Myocardial excitability and contractility was also reduced. 
               Nor-epinephrine released by postganglionic sympathetic axons, acting 
via β adrenergic receptors, mainly increases the heart rate and the conduction. 
Myocardial excitability and contractility was also increased. When arterial 
pressure increases, the vagal neurons are mostly activated via the baroreflex. 
But during inspiration these are inhibited, due to the action of acetylcholine 
that acts immediately and is fastly inactivated by an enzyme acetyl 
cholinesterase. Thus the vagus controls the heart rate on a beat to beat basis. 
               By activating α-adrenergic receptors, it produces vasoconstriction, 
when the sympathetic outflow is, to the arteries, arterioles and veins of the 
peripheral   circulation.  Sympathetic activation causes splanchnic 
vasoconstriction that is essential for to maintain the upright posture. Thus, loss 
of splanchnic vasomotor outflow is the main mechanism that causes orthostatic 
hypotension in autonomic failure 
(20)
. 
        There are variety of reflexes that controls the Autonomic outflow to the 
heart and blood vessels. They are mainly initiated by arterial baroreceptors 
and chemo receptors.  Arterial baroreflex are the one which provides a 
negative feedback mechanism that buffers fluctuations in arterial blood 
pressure.  Carotid sinus located in the bifurcation of the common carotid artery 
and the aortic arch serves as baroreceptors.    
       As blood pressure raises nerve endings situated in the walls of the vessels 
are stimulated. The afferent fibres from the carotid sinus ascend on the 
glossopharyngeal nerve and terminate in the nucleus of tractus salitarious. The 
afferent fibres from the aortic   arch ascend in the vagus nerve.  Connector 
neurons in the medulla oblongata activate the parasympathetic nucleus of the 
vagus which slows the heart rate. At the same time reticulospinal fires descend 
to the spinal cord and inhibit the Preganglionic sympathetic outflow to the heart 
and cutaneous arterioles. The combined effect of stimulation of the 
parasympathetic action on the heart and inhibition of the sympathetic action on 
the heart and peripheral blood vessels reduces the rate and force of contraction 
of the heart and reduces the peripheral resistance of the blood vessels that leads 
to fall in blood pressure. 
         During standing, the blood pressure falls, and then the baroreceptors are 
“unloaded”. Their afferent discharge to the NTS decreases which results in 
reflex sympathetic excitation and parasympathetic inhibition, that causes 
vasoconstriction and tachycardia 
(20, 26, 27)
. 
SKIN: 
                    Skin innervated by sympathetic neurons, plays an important role in 
the thermoregulation and during the expression of emotional states. T2-T3 
segments of the spinal cord controls the vasomotor activity and sweating in the 
face is via the superior cervical ganglion.  In the ears and lips sympathetic flow 
produces vasoconstriction but in rest of the face it predominantly produces 
vasodilatation. 
              Cold produces vasoconstriction (pallor) of the skin and piloerection 
(goose flesh) via α-adrenergic mechanisms. Exposure to warm causes 
vasodilatation and through   Muscarinic receptors it produces sweating.   Both   
vasoconstrictor and   sudomotor outputs are simultaneously activated 
producing a cold, clammy skin during certain emotional states   and 
hemodynamic   stimuli 
(20)
. 
 
GASTROINTESTINAL TRACT: 
                 The entire gastrointestinal tract was innervated by the dorsal nucleus 
of the vagus except the proximal esophagus, distal colon and rectum.  Increases 
in propulsive motility, relaxation of sphincters are produced by vagus.  Vagus 
also increases the secretions of the exocrine and endocrine glands of the 
internal viscera like stomach, intestine, pancreas, and liver. Sympathetic 
outflow to the gastrointestinal tract that arises from Preganglionic neurons at 
the level of T1-L1 segments of the spinal cord via the splanchnic nerves is 
involved in certain reflexes which decrease the gut motility. 
URINARY BLADDER: 
               Through activation of detrusor muscle and relaxation of the bladder 
neck by the parasympathetic nerves promotes bladder emptying.  Relaxation of 
detrusor muscle and contraction of the bladder neck are produced by 
sympathetic nerves, which favours the storage of urine. The sacral 
somatomotor output, that arises from motor neurons of the nucleus of Onuf 
(S2-S4) and which is carried by the pudendal nerve, stimulates contraction of 
the external sphincter via nicotinic receptors. Activation of these somatomotor 
nerves also promotes storage of urine 
(20)
. 
EYES:  
        Two functions of the eyes are controlled by the autonomic nervous 
system. They are pupillary opening and the focus of the lens. 
       Dilatation of pupil is achieved by sympathetic stimulation that contracts 
the meridional fibres of the Iris. Constriction of pupil is by parasympathetic 
stimulation that contracts the circular muscle of the Iris.  
GLANDS: 
       Stimulation of nasal, lacrimal, salivary and many gastrointestinal glands by 
the parasympathetic nervous system, results in copious quantities of watery 
secretion. The sweat glands and apocrine glands are stimulated by the 
sympathetic nervous system and they do not respond to parasympathetic 
stimulation 
(20)
. 
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SYMPATHETIC 
ACTION 
PARASYMPATHETIC 
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HEART 
SA NODE ↑ Heart rate(β1,β2) ↓Heart rate 
AV NODE ↑ 
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(β1,β2) 
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Figure No: 2 Physiological effects of ANS 
AUTONOMIC FUNCTION TESTS:  
                        A wide variety of autonomic reflex tests have been devised to 
assess different component of autonomic nervous system. The sympathetic 
function tests are Heart rate, Blood pressure, Mean arithmetic mean, QTc 
interval, and Cold presser test, for assessing parasympathetic function the tests 
are Standing/Lying ratio, Expiration/Inspiration ratio, Valsalva ratio, 30:15 
ratio. 
HEART RATE and BLOOD PRESSURE: 
               The autonomic nervous system is the primary system for regulating 
heart rate in normal persons. Increase in heart rate is achieved through increase 
in contractile frequency via sympathetic activation. This is in part mediated 
through the arterial baroreflex 
(28)
. 
       Moodithaya et al., (2009) demonstrated Heart rate variability using spectral 
analysis and their studies showed lower heart rate variability in post 
menopausal women compared to that of young women. Further decline in 
estrogen level is associated with sympathovagal balance in postmenopausal 
women. 
          The sympathetic influence is achieved by release of epinephrine and nor-
epinephrine, which causes cAMP mediated phosphorylation of membrane 
proteins and a resultant increase in the inward calcium current, resulting in 
accelerated slow diastolic depolarization. Also other endogenous factors, such 
as Nitric oxide, influence channel function and further modulate autonomic 
control of heart rate. 
        Latif Afrin Dill Naher et al., observed increased resting systolic and 
diastolic pressure in postmenopausal women, which indicates increased 
sympathetic activity due to low estrogen level 
(29)
. 
       The study done by C.L.Brockbank et al., showed reduction in the heart rate 
variability, associated with increase in the heart rate 
(30)
. 
      Brian E. Hunt et al., studied the improvement of Baroreflex activity after 
the administration of estrogen in the postmenopausal women 
(31)
.
 
 
ORTHOSTASIS:    
        Orthostatic hypotension is defined as a decrease of more than 20 mmHg in 
systolic pressure or a decrease of more than 10 mmHg in a diastolic pressure 
after raising to a standing position from a supine position. Orthostatic 
hypotension is an ability of the cardiopulmonary system to maintain sufficient 
blood pressure and adequate cerebral perfusion against gravity. Generally on 
rising from a supine position, an average person may lose 700ml of blood from 
the thorax. This results in decreased stroke volume as well as decreased 
systolic pressure and increased diastolic pressure. Compensation occurs via an 
increase in heart rate and slight peripheral vasoconstriction. Individuals 
intolerant to orthostasis may get venous pooling secondary to decreased muscle 
and vascular tone and may develop a decreased circulating blood volume in 
response to standing 
(28)
. 
           Kevin D.Monahan (2007) showed that the magnitude of the decrease in 
blood pressure is associated with lower levels of cardiovagal baroreflex 
sensitivity in older adults 
(32)
. 
COLD PRESSOR TEST: 
        The cold pressor test is performed by the subject submerging a hand in ice 
cold water while blood pressure is assessed. The afferent limb is somatic, 
efferent limb of the reflex is sympathetic and a normal response is an elevation 
of blood pressure. The cold pressor test has been reported to a valuable in the 
assessment of baroreceptor failure and diabetic autonomic neuropathy.  
Anjali Nadir Bhat (2005) showed significant variation in 
postmenopausal women. Their studies suggested the increased sympathetic 
reactivity in the postmenopausal period
 (4)
. 
MEAN ARITHMETIC MEAN: 
            Mental stress like arithmetic, noise or emotional stress can result in 
increase in blood pressure and heart rate due to excessive sympathetic outflow. 
It is a useful measure of sympathetic efferent function.  
G.nyberg et al., (1977) found that mental arithmetic stress caused 
increase in the heart rate and blood pressure in normotensive males and 
hypertensive subjects of both sexes 
(33)
. 
 Mi Kyong PARK et al., observed increased blood pressure of MAM in 
postmenopausal and perimenopausal women due to vasoconstriction caused by 
the sympathetic activation 
(34)
 
QTc INTERVAL: 
            The QT interval is an indirect measure of the duration of Ventricular 
depolarization and repolarization. It varies with heart rate. Thus corrected QT 
interval is calculated using Bazett’s formula. 
 Arduino A.Mangoni et al demonstrated the prolongation of QTc 
interval in older groups. This prolongation was due to increase in vascular 
impedance that leads to an increase in systolic blood pressure. The increase in 
left ventricular wall thickness appears to be an etiological factor in the older 
age groups.  
Their studies also showed gender related differences in which women 
had longer QTc values than men. This gender related differences are due to the 
prolongation of repolarisation duration in women and are also related to sex 
hormones 
(35)
. 
VALSALVA RATIO:
 
              The Valsalva maneuver occurs when intrathoracic and intra-abdominal 
pressure is increased during a straining procedure. The Valsalva maneuver and 
the cardiovascular responses that follow can be divided into four phases. 
 
Phase I:  
  Phase I occurs at the onset of strain. There is transient increase in 
arterial blood pressure lasting for a few seconds, which is due to increased 
intrathoracic pressure and mechanical compression of the great vessels. The 
heart rate does not change in this phase. 
Phase II:  
  Phase II occurs during straining. In the earlier part, the venous return 
decreases resulting in reduction of stroke volume, cardiac output, and blood 
pressure, which lasts about 4 seconds. In the latter part of phase I, blood 
pressure returns toward baseline. This recovery occurs due to increased 
peripheral vascular resistance as a result of sympathetic vasoconstriction. 
Throughout phase II, the heart rate increases steadily, which is due to vagal 
withdrawal in the early and increased sympathetic activity in later part of 
stageII. 
Phase III:  
  Phase III recorded after the release of strain, which results in transient 
decrease of arterial blood pressure lasting for a few seconds.  
Phase IV:  
Phase IV occurs with further cessation of strain. The arterial blood 
pressure slowly increases and heart rate falls. Since the blood pressure rises to 
above and the heart rate falls below baseline level, it is called overshoot 
phenomenon. It occurs following 15-20 seconds after release of strain and may 
last for 1minute or longer. The overshoot phenomenon is due to increase in 
venous return, stroke volume, and cardiac output. Valsalva ratio is the ratio of 
maximum heart rate in phase II to minimal heart rate in    phase IV and can be   
calculated as the longest RR interval during phase IV to the shortest RR 
interval of phase II. 
Naher LAD (2009) observed lower values of valsalva ratio in 
postmenopausal compared with premenopausal women. He also showed 
positive correlation between valsalva and serum estrogen level in 
postmenopausal women 
(8)
. 
30:15 RATIO: 
            Normally on standing exercise reflex and mechanical effects on venous 
capacitance and arterial resistance vessels become operative in addition to 
gravitational changes. Compression of capacitance vessels by postural muscle 
results in displacement of blood towards the heart that increases the venous 
return, cardiac output, and blood pressure. During this time baroreceptors are 
stimulated, that reduce the sympathetic outflow, release vasoconstrictor tone, 
and decrease total peripheral resistance, which results in the drop of blood 
pressure.   It last for about 6-8 seconds. 
              During standing heart rate increases and is continued to increase for 
next few seconds and then fall to a maximum by 20 secs. Parasympathetic 
withdrawal is the main reason for the heart rate changes.   
           G.V.Lathadevi et al (2011) showed slight difference in this test when 
compared with perimenopausal women and postmenopausal women; in which 
‘p’ value is insignificant indicating reduced parasympathetic activity in 
postmenopausal women 
(3)
.  
EXPIRATION: INSPIRATION: 
              The study of heart rate variation with respiration is indicated for 
testing the integrity of sympathetic cholinergic functions. The variation of heart 
rate with respiration is known as sinus arrhythmia, which is generated by 
autonomic reflexes. This phenomenon is primarily mediated by vagal 
innervations of heart. 
        Naher LAD (2009) showed lower value of heart rate response to deep 
breathing in postmenopausal women when compared to postmenopausal 
women 
(8)
.   
AUTONOMIC DYSFUNCTION: 
          We have found major advances in recognizing, investigating and treating 
the autonomic disorders. Advances in non-invasive technology have resulted in 
more accurate   pathophysiological mechanisims that enables the targeted 
therapy for autonomic dysfunction. 
           Dysautonomias refer to any dysfunction of the autonomic nervous 
system, may be central, peripheral or secondary to other disease processes. The 
autonomic nervous system has craniosacral parasympathetic and thoracolumbar 
sympathetic pathways and supplies every organ in the body. This system 
controls the vital functions especially the arterial blood pressure and body 
temperature. Neurotransmitters in every pathway influence Preganglionic and 
post ganglionic activity. Thus autonomic diseases would occur with lesions at 
different sites in the brain, spinal cord or periphery 
(36)
. 
Classification of autonomic dysfunction: 
          Autonomic dysfunction may be classified into localized and generalized 
disorders. Localized disorders affect a particular organ. Generalized disorders 
mostly affect systems. They are said to be primary when the cause is not 
known, and is secondary when combined with a specific disease. Drugs also 
cause of autonomic dysfunction, due to autonomic nerve damage. Damage to 
the Autonomic nervous system usually causes irreversible abnormalities 
           It also can be classified as sympathetic and parasympathetic 
dysautonomias. The most common dysautonomias are those affecting the 
sympathetic system and may be characterized by disorders of release, function 
or re-uptake of the main sympathetic chemical messenger, nor-epinephrine. 
Furthermore, local blood flow and clearance of nor-epinephrine from the 
circulation may manifest as a dysautonomia. 
               The sympathetic dysautonomias can be generally divided into two 
groups, those associated with decreased function, in which orthostasis often 
occurs and those associated with increased outflow, in which hypertension or 
tachycardia may be present. 
         The parasympathetic dysautonomias are most often reflected as increase 
in parasympathetic tone and manifest as exaggerated responses to normal 
physiologic conditions. Typically parasympathetic tone predominates at rest in 
normal humans and is balanced by local and neurohormonal responses.  
 Clinical features: 
a) Postural hypotension is caused by sympathetic adrenergic failure.  
b) Sympathetic cholinergic failure causes anhydrosis. 
c)  Dilated pupils, atonic large bowel is caused by Parasympathetic failure. 
Cardiovascular system: 
Orthostatic hypotension: 
          Orthostatic or postural hypotension is defined as fall in blood 
pressure of 20mm Hg of   systolic or 10mm Hg of diastolic while standing. 
Orthostatic symptoms include lightheadedness, palpitations, tremulousness, 
visual changes, discomfort or throbbing of the head, poor concentration, 
tiredness, weakness and occasionally fainting
 (36)
. 
     Pathophysiology: 
         The potential pathophysiological causes include excessive venous 
pooling, a gravity dependent fluid shift, diminished plasma volume or red 
cell mass and dysfunction of the nor-epinephrine transporter. Genetic 
etiologies are also responsible. This may be due to nor-epinephrine 
transporter deficiency. It derives from a unique A453p mutation yielding 
loss of gene function. 
             Gonadal hormones may affect homeostatic mechanism regulating 
the cardiovascular system. Another reason includes an estrogen-dependent 
change of the plasma volume or a direct estrogen receptor-mediated 
modulation of vascular reactivity. The presence of estrogen receptors in the 
heart, vascular smooth muscle, and hormone-mediated change in 
adrenoreceptor density, cAMP levels, and Nitric oxide synthase activity 
suggest a possible involvement in the regulation of the cardiovascular 
system. 
             Estrogen acts on endothelial cells to increase the response to 
acetylcholine by relaxation. It may also act directly on vascular smooth 
muscle. 
Hypertension: 
              Estrogen either from endogenous or exogenous sources would 
likely to influence the neurogenic mechanism of blood pressure regulation. 
The symptoms associated are throbbing headache, palpitations
 (37)
. 
         Loss of baroreflex buffering mechanisms results in prolonged and 
exaggerated responses to a variety of tests, such as the cold pressor test. 
         Initial therapy over the first 72 hrs may include nitroprusside and 
clonidine.Chronically patient may continue to have labile hypertension and 
tachycardia alternating with hypotension and bradycardia. This may be 
effectively treated with clonidine and methyldopa . 
Estrogen Therapy: 
 Estrogens can be supplemented for the menopausal women to reduce the 
vasomotor symptoms. Various route of administering estrogens are oral, 
parenteral, topical, or transdermal routes
 (11)
. 
The most commonly used oral estrogen preparation is 
Conjugated equine estrogen -    0.625 to 1.25 mg daily 
Transdermal preparation: 
           17 β estradiol              - 0.025 to 0.1 mg patch applied twice daily 
Parenteral preparation: 
            Estrone                           - 0.1 to 1 mg weekly                  
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
              This study was undertaken to compare the Autonomic functions in the 
perimenopausal women with postmenopausal women. Prospective non-
interventional type of study was done. The study period extended from may 
2011-2012. The subjects were selected from Thanjavur Medical College 
Hospital and Raja Mirasudar Hospital, Thanjavur. This study was performed on 
healthy women of age 45-55 yrs of perimenopausal and postmenopausal 
women. 
              Perimenopausal  period refers to a period, in which there would be 
declining  of ovarian functions with menstrual irregularities, vasomotor 
symptoms that ends 12 months after the final menstrual period. 
           Menopause: The permanent cessation of menstrual cycle for a period of 
one year or more. 
         The nature of study was explained to all the subjects. Informed written 
consent was obtained from all the participants. The experimental protocol was 
approved by the Ethical committee. 
INCLUSION CRITERIA: 
            Healthy women of 45-55 yrs of age with 
 irregular menstrual cycle  
 cessation of menstrual cycle 
 
 Symptoms of menopause which includes flushing, sweating. 
EXCLUSION CRITERIA: 
 Diabetics 
 Hypertension 
 Cardiovascular disorders 
 Renal  disorder 
 Liver disorder 
 Smoking 
 Alcohol 
 Oral pills 
 Hormone  replacement therapy 
MATERIALS FOR THE STUDY: 
1. Proforma to record the subject details and clinical examination findings. 
2. Electrocardiograph 
3. ECG-paper 
4. ECG-jelly 
5. Sphygmomanometer 
6. Cotton 
7. Ice cold water 
8. Stethoscope 
METHODOLOGY: 
The study was carried out after explaining the procedure in detail and 
getting informed consent from the subjects. The experimental protocol was 
1. A proforma with detailed history from the study subjects was filled. 
2. A thorough clinical examination of the study subjects was done. 
A detailed history regarding name, address, op.no, age , FMP(first 
menstrual period), LMP(last menstrual period), menopausal symptoms like hot 
flushes, sweating, past history regarding previous medical illness, family 
history regarding,  mother’s age of menopause, marital history. 
A detailed general examination was carried out in the subjects including 
pulse rate, blood pressure, pedal edema, icterus, cyanosis, lymphadenopathy, 
and examination of CVS, RS, CNS, and Abdomen. 
Baseline laboratory investigations were done for all the subjects 
including Blood sugar, hemoglobin, urine albumin and sugar. 
For assessing the Autonomic functions the following tests were carried out: 
For performing these tests ECG was recorded by a simple compact 
Electrocardiograph (Model No:Cardiofax, Manufactured by Medicaid systems) 
SYMPATHETIC FUNCTION TESTS: 
1. PULSE RATE:  Pulse   rate was taken by palpatory method 
2. BLOOD PRESSURE: 
Blood pressure was recorded in all the subjects, after 5 minutes of rest in 
sitting posture, either in the left or right arm, using sphygmomanometer, with 
the apparatus at the heart level 
(40)
. Blood pressure was recorded by palpatory 
and auscultatory method. 
Normal variation of   Systolic Blood pressure - 100-140mmHg 
Diastolic Blood pressure- 60-84mmHg 
3. ORTHOSTASIS: 
This is a simple test for assessing the integrity of sympathetic pathway. 
Blood pressure was recorded for the patient in supine position and immediately 
after standing for two minutes. 
A fall in systolic blood pressure of 20mmHg or more or/and a fall in diastolic 
blood pressure greater than 10mmHg upon standing is abnormal. 
4. COLD PRESSOR TEST: 
The subject was asked to submerge one of her upperlimb in the ice cold 
water at 4
o
 C. The blood pressure was recorded at the end of 30 seconds of 
immersion and at the end of 60 seconds from the other arm. 
A rise in systolic blood pressure greater than 20mmHg and an increase 
in diastolic blood pressure more than 10mmHg were considered abnormal 
(38)
. 
5. MEAN ARITHMETIC MEAN: 
It is a useful measure of sympathetic efferent function. The subject was 
made to solve some mathematical problem like to subtract 7 from 100 as 
quickly as possible and the blood pressure was recorded. The rise in blood 
pressure shows sympathetic overactivity 
(39)
. 
6. CORRECTED QT INTERVAL: 
QT interval was measured from the electrocardiograph and then 
standardized by converting it to QTc.  For this Bazett’s formula was used. 
Normal value: 0.35 secs to 0.43 secs 
PARASYMPATHETIC FUNCTION TESTS: 
1. VALSALVA MANEUVER: 
The subject was asked to sit in a stool with sphygmomanometer and 
ECG leads should be attached. The technique involves the subjects to blow into 
a mouthpiece connected to a manometer up to 40mmHg for 15 seconds and 
asked to stop blowing 
(38, 39, 40)
. 
A continuous ECG was recorded in standard lead II during the straining 
period and immediately after the release for 30 seconds. The valsalva ratio was 
calculated as follows: 
                            Longest R-R interval after the strain 
Valsalva Ratio =      --------------------------------------------- 
                            Shortest R-R interval during the strain 
A ratio of       > 1.45        - normal 
1.2 to 1.45 - borderline 
< 1.2           - abnormal 
2. EXPIRATORY: INSPIRATORY RATIO: 
To assess the heart rate response to deep breath at 6 cycles per minute. 
The subject was asked to lie down comfortably in the supine position and was 
connected to ECG machine. 
The subject was instructed to breathe deeply at a rate of six breaths/min 
(allowing 5 secs each for inspiration and expiration). The maximum and 
minimum heart rate was recorded in lead II with each respiratory cycle 
(41, 42)
 
It is calculated as: 
                         Mean of longest R-R interval during expiration 
E: I Ratio=         --------------------------------------------------------- 
                        Shortest R-R interval during inspiration 
Normal         > 1.21 
Borderline    1.11 to 1.2 
Abnormal     < 1.10 
 
3. STANDING / LYING RATIO: 
To assess the heart rate response in lying posture from standing position. 
The subject was asked to stand quietly and then lie down without any support. 
A continuous ECG was recorded from 10 beats before and 20 beats after lying 
down. Thus, the standing /lying ratio was calculated as follows: 
                           Longest R-R interval during 5 beats before lying down 
S/L   Ratio       =   ------------------------------------------------------------------ 
                           Shortest R-R interval during 15 beats after lying down 
Normal >1.01 
4. 30:15 RATIO: 
To assess heart rate response to standing up from lying position. The 
subject was asked to lie down quietly on a couch and then to stand up and the 
heart rate was recorded in lead II ECG machine continuously during standing 
up period for more than 30 beats 
(42)
.  
The 30:15 ratio was calculated as 
                  Longest R-R interval around 30
th
 beat 
30:15=       ----------------------------------------------- 
                  Shortest R-R interval around 15
th
 beat 
Normal        >1.04 
Borderline   1.01 to 1.03 
Abnormal   <1.0 
STATISTICAL ANALYSIS: 
Statistical analysis was done by using statistical package for social 
sciences (SPSS) XVIII version. The results were analyzed by the student‘t’ 
test. 
BIOCHEMICAL ANALYSIS: 
The altered autonomic functions in postmenopausal women are due to 
decreased level of estrogen. To substantiate this, estrogen levels were 
determined by the method of electro-chemiluminescence immunoassay. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure No:3 AN ELECTROCARDIOGRAPH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 4.   30 : 15 Test :  R-R Intervals during the 15th beat & 30th beat 
in Postmenopausal women. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure No: 5.    Standing / Lying Ratio :  R-R intervals during standing & 
Lying in Postmenopausal women.  
 
 
 
 
 
 
 
 
 
 
 
 Figure No:6.  Valsalva Ratio test :  ECG Recordings showing R-R 
intervals during the strain & after the release of strain in postmenopausal 
women. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure No: 7.   E.I Ratio : ECG recordings showing R-R intervals during 
Inspiration & Expiration in postmenopausal  women 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure No:8 CHEMILUMINESCENCE IMMUNOASSAY 
INSTRUMENT 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure No:9 SERUM ESTROGEN ASSAY KIT 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                     
 
 
 
RESULTS 
                A prospective, non-interventional study was conducted in 80 
subjects. Their age varied from 45-55 yrs.  
Subjects who self reported with the H/O menstrual irregularities, 
irritability, sleep disturbances were included in perimenopausal group and are 
considered as Group A. 
Subjects who self reported with H/O amenorrhea more than a year 
associated with vasomotor symptoms like hot flushes, night sweats were 
included in postmenopausal group and are considered as Group B. 
  The parameters evaluated in this study are sympathetic function tests 
which includes Pulse rate, Blood pressure, Orthostasis, Mean arithmetic mean, 
Cold  pressor test, QTc. Parasympathetic function tests that includes Valsalva 
ratio, Expiration: Inspiration ratio, Standing: Lying ratio,30:15 ratio. Serum 
estrogen was done for both the groups. 
             The mean and standard deviation values of all the parameters tested in 
postmenopausal women were compared with the perimenopausal women. The 
results were analyzed by the student’s t-test.   The statistical significance was 
considered at P< 0.05. 
 These parameters were correlated with serum estrogen level by using 
Pearson’s correlation coefficient test. 
    
Table No: 1 
 Descriptive Analysis
                      
                                                 
 
 
 
 
 
 
 
 
 
 
 
 
The baseline characteristics of Group A are shown in the table.  
 
 
 
Item  
Group A (n=40) 
Min Max Mean S.D 
Age 45 53 49.23 2.486 
PR 68 96 84.25 7.389 
Supine BP SBP 100 130 114.90 9.713 
Supine BP DBP 60 90 74.75 5.986 
Orthostasis SBP 90 130 106.35 10.688 
Orthostasis DBP 60 80 71.75 5.006 
Ortho variation 0 30 8.55 11.749 
MAM SBP 110 130 119.35 7.167 
MAM DBP 70 90 75.25 5.986 
CPT SBP 110 130 119.75 7.334 
CPT DBP 70 90 78.00 6.485 
QTc .20 .50 .3560 .07292 
Valsal Ra 1.03 1.32 1.2232 .07301 
S:L Ra .70 108.00 3.7233 16.91081 
30:15 Ra .80 1.20 1.0660 .07635 
E:I Ra 1.00 1.37 1.2270 .09487 
Estrogen pg/dl 7.56 192.05 94.3275 47.15459 
Table No: 2  
Descriptive Analysis 
Item  
Group B (n=40) 
Min Max Mean S.D 
Age 46 55 51.83 2.809 
PR 70 98 84.70 5.984 
Supine  SBP 100 134 120.65 7.252 
Supine  DBP 60 84 77.10 5.728 
Orthostasis SBP 90 120 103.05 7.961 
Orthostasis DBP 60 80 69.95 4.356 
Ortho variation 0 30 17.30 8.259 
MAM SBP 110 140 123.15 6.912 
MAM DBP 70 90 78.75 4.043 
CPT SBP 100 130 121.55 8.283 
CPT DBP 70 90 79.75 4.797 
QTc .23 .56 .3631 .10093 
Valsal Ra .77 1.53 1.0785 .1593 
S:L Ra .63 1.20 .8838 .11401 
30:15 Ra .70 1.18 .9675 .10051 
E:I Ra .80 1.30 1.0805 .10318 
Estrogen pg/dl 5.00 184.40 46.0588 46.10235 
            
              The baseline characteristics of Group B are shown in the table. 
 
 
 
 
Table No. 3 
Comparison of Sympathetic Functions 
 
          Parameters 
Group A 
n=40 
Mean SD 
Group B 
n=40 
Mean SD 
 
 P  value 
                 PR   81.4 7.456 87.4   7.063 
 
0.001* 
 
Supine BP 
SBP 114.9  9.71 120.65   7.25 0.004* 
 
DBP 74.75  5.98 77.10  5.728 0.07 
 
 
Standing BP 
 
SBP 106.35 10.68 103.05 7.961 0.02* 
 
DBP 71.75 5.006 61.95 4.356 0.09 
 
Orthostatic Variation 8.55 11.75 17.30 8.259 
0.001* 
 
 
(* P value less than 0.05 was considered to be significant) 
 The mean ±SD of pulse rate for Group B was 87.4±7.063 and for Group 
A was 81.4±7.456. It was found to be statistically increased (P=0.001). 
The mean ±SD values of Supine systolic BP for Group B and Group A 
were 120.65±7.25and 114.9±9.71 respectively. It was found to be statistically 
significant (P=0.004), that shows the increased sympathetic activity. 
The mean values of Supine Diastolic BP for Group B and Group A were 
77.10±5.7288and 74.75±5.98 respectively. It was found to be statistically 
insignificant (P=0.09). 
The mean values of Orthostatic variation ( Systolic BP) in Group B and  
Group A were 17.3±8.259 and 8.55±11.75 respectively , which was found to be  
statistically significant (P<0.001). 
 
 
 
Figure No:10  Parameters reflecting  the sympathetic activity 
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                                                   Table No:4 
Comparison of Autonomic functions 
Parameters 
Group A 
n=40 
mean±SD 
Group B 
n=40 
mean±SD 
P value 
MAM 
SBP 119.35±7.16 123.15±6.91 0.018* 
DBP 75.25±5.98 78.75±4.04 0.003* 
CPT 
SBP 
119.75±7.33 121.55±8.28 0.31 
DBP 
78±6.48 79.75±4.79           0.17 
QTc 0.34±0.07 0.36±0.10 0.019* 
 
             The mean value of Mental arithmetic mean(systolic BP) in  Group B 
was 123.15±6.912 and  for Group A  119.35±7.167. It was found to be  
significantly increased (P=0.018). The mean value of Mean arithmetic 
mean(Diastolic BP)  in Group B and  Group A were 78.75±4.043 and 
75.25±5.986 respectively.The P value was 0.003, which was found to be 
statistically  significant. 
In Cold pressor test, the mean of Systolic BP was 121.55±8.283 for  
Group B and  for Group A 119.75±7.334. The mean of diastolic BP was 
79.75±4.79 for  Group B and 78.00±6.485 for  Group A. The mean values of 
systolic and diastolic BP were increased  in Group B when compared with  
Group A but not statistically significant.  
The mean and standard deviation value of QTc interval for  Group B 
was 0.363±0.100 and  for Group A 0.346±0.729. It was found to be statiscally 
significant (P=0.019). 
 
 
 
Figure No.11  Parameters reflecting the Sympathetic activity 
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                                                       Table no:5 
                           Comparison of Parasympathetic functions 
 
 
The mean and standard deviation value of Valsalva ratio test for Group 
B was 1.08±0.11 and for Group A 1.22±0.07. It was found to be significantly 
reduced (P<0.001). 
 The mean and standard deviation value of Standing / lying ratio for 
Group B and Group A were 0.88±0.11 and 3.72±16.91 respectively. It was not 
found to be statistically significant (P=0.29). 
The mean and standard deviation value of 30:15 ratio for Group B was 
0.96±0.100 and for Group A 1.06±0.07. It was found to be statistically 
significant (P<0.001). 
 
 
Parameters 
Group A 
n=40 
Mean±SD 
Group B 
n=40 
Mean±SD 
P value 
Valsalva  Ra. 1.22±0.07 1.08±0.11 < 0.001* 
S / L Ra. 3.72±16.91 0.88±0.11 0.29 
30 : 15 Ra. 1.06±0.07 0.96±0.10 < 0.001* 
E : I Ra. 1.22±0.09 1.08±0.10 < 0.001* 
 The mean and standard deviation value of E: I ratio for Group B and 
Group A were 1.08±0.10 and 1.22±0.09 respectively. It was found to be 
significantly reduced (P<0.001), thus reflecting decreased parasympathetic 
activity. 
 
 
Figure No:  12 
The parameters reflecting the Parasympathetic activity  
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Table   No:6 
 Comparison of  Serum Estrogen levels in Group A and Group B 
Estrogen pg/dl Mean S.D P value 
Group A (n=40) 94.3275 47.15459  
< 0.001* 
 
Group B (n=40) 46.0587 46.10235 
 
The mean and standard  deviation value of estrogen in  Group B was 
46.05±46.10 and for Group A 94.32±47.15, which was found to be  
significantly reduced (P<0.001).  
 
Figure No:13 
 Comparison of Sr.Estrogen levels in Group A  and  Group B 
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                                                      Table No:7 
Correlation of Sr.Estrogen levels with Valsalva ratio in  Group B 
Parameter Correlation value     ‘r’ P value 
Valsalva Ratio 0.5857 0.001 
 
Valsalva ratio showed positive correlation with serum estrogen level in  
Group B and the relation was found to be statistically significant. 
 
 
                                                          Figure No:14 
Correlation of Sr.Estrogen levels with Valsalva ratio in  Group B 
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Table No:8 
Correlation of Sr.Estrogen levels with Valsalva ratio in  Group A 
Parameter Correlation value- ‘r’ P value 
Valsalva  ratio -0.0673 0.6 
 
Valsalva ratio showed negative correlation with Sr.estrogen levels in   
Group A. It was found to be statistically insignificant. 
 
 
Figure No: 15 
Correlation of Sr.Estrogen levels with Valsalva ratio in   Group A 
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                                                 Table No:9 
Correlation of Sr.Estrogen levels with  E:I ratio in  Group B 
 
Parameter Correlation value     ‘r’ P value 
E:I  Ratio 0.5429 0.0003 
 
` E : I ratio was positively correlated with serum estrogen level in  Group 
B  and it was found to be statistically significant. 
 
Figure No: 16 
Correlation of Sr.Estrogen levels with E:I ratio in  Group B 
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Table No:10 
Correlation of Sr.Estrogen levels with E:I ratio in  Group A 
Parameter Correlation value-‘r’ P value 
E:I ratio -0.1561 0.3360 
 
E:I ratio showed negative correlation with Sr.estrogen levels in  Group A. It 
was found to be statistically insignificant. 
 
 
Figure No: 17 
Correlation of Sr.Estrogen levels with E:I ratio in  Group A  
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                                                       Table No:11 
Correlation of Sr.Estrogen levels with 30:15 ratio in  Group B 
Parameter Correlation value     ‘r’ P value 
30:15 Ratio 0.3136 0.04 
 
30:15 ratio was positively correlated with serum estrogen level in Group 
B and it was found to be statistically significant. 
 
 
Figure No: 18 
Correlation of Sr.Estrogen levels with 30:15 ratio in  Group B 
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Table No:12 
Correlation of Sr.Estrogen levels with  30:15 ratio Group A 
Parameter Correlation value     ‘r’ P value 
30:15 Ratio -0.2584 0.107 
 
30:15  ratio showed negative correlation with Sr.estrogen levels in   
Group A. It was found to be statistically insignificant. 
 
Figure No: 19 
Correlation of Sr.Estrogen levels with 30:15 ratio in  Group A 
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DISCUSSION 
           Menopause is a normal aging phenomenon in women. Perimenopause 
in life is a critical period during which endocrinological, psychological, and 
somatic alterations occur in the transition to menopause. The perimenopausal 
period includes the changes from the ovulatory cycle, up to the cessation of 
mensus. The serum estradiol levels do not decline until less than a year before  
menopause. 
                Menopause is the permanent cessation of mensus as a result of 
irreversible loss of a number of ovarian functions including ovulation and 
estrogen production. These women often suffer from various menopausal 
complications including autonomic nerve dysfunction. Postmenopausal women 
reported more vasomotor symptoms like hot flushes, sweating when compared 
with perimenopausal women.  
In this study, Sr. estrogen levels of postmenopausal women showed 
significantly reduced values, when compared to the perimenopausal women. 
The present study has shown significant alteration in the autonomic function 
tests, which includes sympathetic as well as the parasympathetic functions. .  
 
 
 
 
Sympathetic function tests: 
Pulse rate and Blood Pressure 
                  The mean ± SD of pulse rate for the postmenopausal women was 
(87.4±7.063), which is significantly higher than the perimenopausal women 
(P=0.001). It shows increased sympathetic activity. 
                Anjali Nadir Bhat et al have studied the   autonomic   functions    in    
healthy   postmenopausal women. Their results showed high significant 
variation in the pulse rate. The present study is congruent with this literature 
cited. Similar findings were observed in the previous studies 
(30, 43, 44,45)
. 
                The supine SBP were found to be significantly elevated in the 
postmenopausal women (120.65±7.25, P=0.004). The DBP was elevated when 
compared to perimenopausal women, though it was not statistically significant 
(77.10±5.728, P=0.07), which reflects the increased sympathetic activity. 
                Latifa Afrin Dill Naher et al., performed sympathetic function tests in 
postmenopausal women and their results showed increased resting SBP and 
DBP, which again reflects the increased sympathetic activity. The present study 
is also congruent with those found by Neves et al, Anjali Nadir Bhat et al, 
Shaher Lavi et al., This study also coincides with the previous study done by 
Ronald E. De meersman et al., who showed decreased systolic and diastolic 
blood pressure after estrogen replacement therapy 
(46)
. 
  
Orthostasis: 
             The present study showed significant fall in systolic BP after standing 
from lying position, which indicates sympathetic hyperactivity in 
postmenopausal women.  
            Latifa Afrin Dill Naher et al observed significant fall in systolic BP 
after standing from lying position. The present study is congruent with this 
literature cited. Anjali Nadir Bhat et al also showed significant variation in 
orthostasis (SBP), which is similar to the present study. Paula J. Harvey et al 
studied the blood pressure responses to orthostasis in healthy postmenopausal 
women, reflecting the influence   of      estrogen   through    renin    angiotensin  
system
 (47)
. 
Cold Pressor Test:           
             In the present study, Cold pressor test (SBP, DBP) showed increased 
mean values, thus indicating an increase in the sympathetic activity, though it 
was not statistiscally significant (SBP-121.55±8.283, P=0.3 and DBP-
79.75±4.797, P=0.17). 
                 L.Mouret et al showed CPT triggers an increase in blood pressure in 
the healthy subjects, that may be due to increased cardiac output and increase 
in muscle sympathetic nerve activity 
(48)
. Similar findings were observed in the 
previous studies by Victor RG et al
 (49)
. 
 
Mental Arithmetic Mean: 
            The present study showed increased SBP and DBP of Mental 
Arithmetic Mean in the postmenopausal women, when compared to the 
perimenopausal women, which was found to be statistically significant(SBP-
123.15±6.912,P=0.01 and DBP-78.75±4.043,P=0.003). It reflects the increase 
in sympathetic activity. 
              Mi Kyong PARK et al observed increased blood pressure of MAM in 
postmenopausal and perimenopausal women due to vasoconstriction caused by 
the sympathetic activation. The present study is congruent with this literature 
cited and also in accordance with the study done by Anjali Nadir Bhat et al. 
Jason R.carter et al studied the sympathetic neural responses to mental stress in 
humans, which showed elevated mean arterial pressure 
(50)
. 
 QTc Interval: 
               In the present study, the mean±SD of QTc interval showed significant 
variation in the postmenopausal women (0.36±0.1, P=0.019), which indicates 
the increased sympathetic activity. 
           ArDuino A.et al studied the relationship between age and QT interval. 
Their results showed prolongation of QT interval with advancing age. They 
explained it may be due to the changes observed in the heart and vasculature of 
the healthy elderly subjects. These include cardiac hypertrophy, increased 
vascular stiffness and aortic impedance. The cardiac hypertrophy is due to an 
increase in size of cardiac myocytes and is associated with a significant 
prolongation of the transmembrane action potential. The present study is also in 
accordance with the Reardon et al 
(51)
, Taneja et al
 (52)
, and Pham TV et al 
(53)
. 
Parasympathetic function tests: 
 Valsalva Ratio: 
              In the present study, mean and SD of the Valsalva ratio showed 
reduced values, which is statistically significant (1.0835±0.11). Thus, it 
indicates the decreased parasympathetic activity. 
         G.V.Lathadevi et al., showed reduced values of valsalva ratio. The 
present study is congruent with this literature cited. Valsalva ratio was 
positively correlated with Sr.estrogen level in the postmenopausal women, 
which showed statistically significant relation. These findings were in 
accordance with Naher LAD et al 
(54)
. 
Expiration: Inspiration Ratio: 
              The mean and SD of E: I ratio in postmenopausal women were found 
to be decreased, which reflects the reduced parasympathetic activity 
(1.0805±0.10, P<0.001). E:I ratio also showed significant positive correlation 
with estrogen level in postmenopausal women, that indicates parasympathetic 
nerve functions, which are associated  with decreased level of estrogen in them. 
Naher LAD et al observed similar findings in postmenopausal women. Similar 
findings were observed in previous studies by Virtanen et al 
(55)
, M.Zi et al 
(56)
.               
 
Standing / Lying ratio:     
               In the present study, mean and SD of Standing / Lying ratio were 
found to be reduced, though it as not statistically significant (0.88±0.11, 
P=0.29).  
             Anjali Nadir Bhat et al also observed the variation in S/L ratio, which 
was statistically insignificant. G.V.Lathadevi et al showed reduced values of 
S/L ratio that was not statistically significant. The present study is in 
accordance with the literature cited. 
    30:15 Ratio:       
                 In this present study, the mean and SD of 30:15 ratio in the 
postmenopausal women showed significantly reduced values (0.9675±0.100, 
P<0.001). It also showed significant positive correlation with Sr.estrogen level 
in postmenopausal women (P=0.004).  Naher et al observed significant 
variation in postmenopausal and also showed positive correlation with 
Sr.estrogen level in postmenopausal women, reflecting reduced 
parasympathetic activity. 
Estrogen: 
                 Estrogens are believed to be potent regulators of mind and mood. 
The present study tested the hypothesis that estrogen exerts regulatory 
influence on ANS in postmenopausal women. 
                In the present study, mean and SD of Sr.estrogen in postmenopausal 
women was significantly lowered when compared to perimenopausal women 
(46.05±46.102, P<0.001).  Latifa Afrin Dill Naher et al showed significantly 
reduced levels of estrogen in postmenopausal women. They also demonstrated 
the increased sympathetic activity and decreased parasympathetic activity in 
postmenopausal women that was related to low estrogen level. 
                Estrogen has a sympatho-inhibitory effect. Estrogens increases 
density as well as the function of presynaptic α2 adrenoreceptors, thereby 
resulting in significant decrease of nor-epinephrine induced responses. So, 
estrogen deficiency in postmenopausal women may lead to increased basal 
level of NE and its vasoconstrictor responses 
(57,58,59)
. 
              Estrogen also acts peripherally to increase vasodilatation by increasing 
the production of Nitric oxide and prostacycline or by decreasing the release of 
endothelin from endothelium 
(60)
. It has direct effect on vascular smooth muscle 
to cause muscle dilatation 
(61)
. 
 Parameters reflecting sympathetic activity like pulse rate, Blood 
pressure, MAM, QTc interval showed a greater proportion in postmenopausal 
women when compared with perimenopausal women which was statistically 
significant. 
 Parameters reflecting parasympathetic activity like valsalva ratio, E:I 
ratio, 30:15 ratio were reduced in postmenopausal women when compared with 
perimenopausal women which was statistically significant. 
  
 
 
 
    
 
 
 
 
 
 
 
 
CONCLUSION 
              The present study shows significant alteration in the Autonomic 
functions of postmenopausal women when compared with perimenopausal 
women.  
               In this study, the result shows increased sympathetic and reduced 
parasympathetic activity in postmenopausal women. 
 Parameters reflecting parasympathetic activity like valsalva ratio, 30:15 
ratio, E:I ratio shows positive correlation with serum estrogen level in 
postmenopausal women.        
              Estrogen levels are reduced in the postmenopausal women, when 
compared with   perimenopausal women that exert a regulatory influence on 
autonomic functions.  
  Cold pressor test reflecting sympathetic activity does not show 
significant increase in perimenopausal women. 
      Standing / lying ratio reflecting parasympathetic activity does not show 
significant decrease in perimenopausal women.  
                    Assessment of sympathetic and parasympathetic functions, could 
therefore aid in early diagnosis of Autonomic dysfunction in postmenopausal 
women. Hence, estrogen may be administered early in them, which would 
prevent the cardiovascular complications.  
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CONSENT FORM 
 
Dr. M.Vijayalakshmi post graduate student in the Department of 
physiology, Thanjavur Medical College, Thanjavur is doing a 
comparative study on autonomic functions in perimenopausal women and 
postmenopausal women. The procedures have been explained to me 
clearly. I understand that there are no risks involved in the above 
procedure. I hereby give my consent to participate in this study. The data 
obtained here may be used for research and publication.   
 
 
Signature: 
 
Name: 
 
Place: 
 
 
 
 
PROFORMA 
TOPIC : Comparison of Autonomic functions in Perimenopausal women 
with Postmenopausal women.   
Name of the Patient / Control: 
AGE : SEX : 
ADDRESS : 
 
OCCUPATION : 
PRESENT H/O : Hot flushes /Sweating /Headache / Dizziness. 
PAST H/O 
: Diabetic / HT / CVS disorders / Renal / Liver diseases / 
Surgical menopause  
PERSONAL H/O : Smoking / Alcohol 
TREATMENT H/O : Oral Pills / HRT. 
FAMILY H/O :  
MENSTRAL H/O         : RMP / IRMP : FMP :  
 No. of Cycles /Month :  LMP : 
 Mother’s age of menopause :  
  
GENERAL EXAMINATION / VITAL SIGNS : 
ANEMIA Ht : Wt : 
CYANOSIS    
CLUBBING   
PEDAL EDEMA :  
JAUNDICE :  
LYMPHADENOPATHY   
PR : BP : RR : 
Examination of  CVS : 
Examination of  RS : 
Examination of  CNS : 
Examination of  Abdomen : 
 
 
SPECIAL INVESTIGATIONS : 
SYMPATHETIC  FUNCTION  TESTS : 
PULSE RATE  
BP  
COLD PRESSOR TEST   
ORTHOSTASIS  
MENTAL ARITHMETIC MEAN  
QT INTERVAL  
 
PARASYMPATHETIC  FUNCTION  TESTS 
VALSALVA MANAVEOUR  
EXP / INS RATIO  
STANDIG / LYING RATIO  
30 :15 RATIO  
 
BIOCHEMICAL ANALYSIS : 
 ROUTINE  INVESTIGATION : 
                               (1). URINE  - ALBUMIN   :                                               
                                                    -  SUGAR       : 
                               (2). RANDOM   BLOOD  SUGAR : 
                               (3). Hb % 
 
SPECIAL INVESTIGATION : 
                                (1). ESTROGEN :                 
 (CLIA)                                        
 
           
 
 
ABBREVIATIONS   USED  IN  THIS  STUDY 
 
ANS                          -     Autonomic Nervous System 
SBP                           -     Systolic Blood Pressure 
DBP                           -     Diastolic Blood Pressure 
CPT                      -     Cold  Pressor Test 
MAM                         -    Mean Arithmetic Mean 
QTc  Interval              -    Corrected QT  Interval 
Val  Ra                       -    Valsalva Ratio 
E:I   Ra                       -     Expiration Ratio 
S/L  Ra                       -     Standing / Lying Ratio 
HRR                           -     Heart Rate Response 
GnRH                         -     Gonadotrophin Releasing Hormone 
FSH                            -     Follicle Stimulating Hormone 
LH                              -     Luteinizing Hormone 
NTS                            -     Nucleus Tractus Solitarious 
FMP                            -      First Menstrual Period 
LMP                            -      Last Menstrual Period 
 
 
 
   
 
 
AUTONOMIC FUNCTION TESTS FOR GROUP B 
 
S.No Age PR 
Supine  BP Orthostasis 
Ort.va 
MAM 
 
CPT 
QTc Val.Ra 
S:L   
Ra 
30:15  
Ra 
E:I  
Ra 
Est 
pg/dl 
Bld. 
sugar 
mgs/dl SBP DBP SBP DBP SBP DBP SBP DBP 
1 50 96 110 80 90 70 20 114 80 110 80 0.29 1.21 0.9 0.93 1.2 44 100 
2 55 90 116 80 90 70 26 114 80 110 80 0.43 1.4 1.2 1.07 2.3 184.4 80 
3 52 100 120 80 110 70 10 120 80 130 80 0.27 1.1 0.84 1.06 1.1 23.42 88 
4 51 90 124 80 110 72 14 130 80 130 90 0.52 0.9 0.78 1 1.1 22.2 85 
5 50 88 128 70 102 60 26 130 70 130 80 0.3 1.1 0.79 0.94 0.94 165.6 77 
6 55 94 120 80 90 70 20 130 80 120 80 0.56 1.26 0.8 0.92 1.25 25.02 89 
7 54 102 130 80 106 76 24 130 80 130 80 0.49 1.1 0.7 1 1.09 27.26 96 
8 55 86 130 70 110 60 20 130 70 130 80 0.31 1.05 0.9 0.9 1.2 26 84 
9 55 88 120 84 102 60 18 120 90 126 80 0.27 1.43 0.9 1 2.3 116.6 114 
10 50 90 120 70 120 70 0 120 70 120 80 0.45 1.07 0.86 0.8 1 25.4 100 
11 55 82 120 60 110 60 10 120 70 120 70 0.3 1.13 0.9 1.05 1.1 40.1 110 
12 53 86 134 80 110 70 24 140 80 130 80 0.5 1.1 0.94 0.94 1 14.36 117 
13 55 84 128 60 110 70 26 140 80 120 80 0.34 0.87 0.9 1.08 0.73 5 100 
14 46 86 120 80 100 70 20 120 80 120 80 0.23 1 0.94 1 2.7 126 40.5 
15 48 84 120 80 102 70 18 126 80 130 80 0.32 1.1 0.96 1 1.21 34.98 82 
16 49 80 130 80 108 70 22 130 80 130 80 0.36 1.1 0.84 1 1 28.05 86 
17 54 82 120 80 104 70 16 120 80 120 80 0.3 1.1 1.1 1 1.11 29.38 90 
18 47 90 110 80 110 80 0 116 80 110 80 0.27 1.33 0.89 0.88 1.01 36.02 110 
19 49 86 120 80 102 70 18 120 80 120 80 0.27 1.23 0.88 1 1 45 68 
S.No Age PR 
Supine  BP Orthostasis 
Ort.va 
MAM 
 
CPT 
QTc Val.Ra 
S:L   
Ra 
30:15  
Ra 
E:I  
Ra 
Est 
pg/dl 
Bld. 
sugar 
mgs/dl SBP DBP SBP DBP SBP DBP SBP DBP 
20 50 84 116 80 90 70 26 120 80 120 80 0.31 1 0.87 1 1 15.05 74 
21 53 76 120 80 100 70 20 120 80 120 80 0.48 1.1 0.94 1.18 1.06 34.8 98 
22 50 74 130 80 110 70 20 130 80 130 80 0.33 1 0.86 1.13 1.1 116.05 96 
23 55 76 120 80 120 80 0 120 80 126 90 0.32 1.1 0.83 1 1.13 54.09 104 
24 50 80 130 80 100 70 20 130 80 130 80 0.29 1.01 0.86 1.12 2.3 81.52 96 
25 53 82 120 80 102 70 18 120 80 120 80 0.55 1.11 0.95 0.94 1 51.32 110 
26 46 86 130 80 100 70 30 130 80 130 90 0.51 1.53 0.63 1.06 2.26 152.02 81 
27 50 88 128 80 100 70 28 130 80 130 80 0.27 0.9 0.89 0.9 1 10.16 98 
28 55 108 116 80 110 80 6 120 80 120 80 0.27 1 0.9 1.11 1 24.54 96 
29 50 94 120 80 100 70 20 120 80 130 90 0.29 0.9 0.76 1.06 2.75 15.15 112 
30 50 98 110 70 90 70 20 120 80 120 80 0.33 0.86 0.89 0.9 1 9.37 98 
31 53 90 110 70 110 70 0 120 80 120 80 0.33 1.04 1.05 0.94 2.26 45.02 102 
32 55 94 120 80 100 70 20 126 80 100 70 0.297 1 0.78 0.92 1.1 15 120 
33 52 88 110 70 110 70 0 110 70 110 70 0.297 1.1 0.73 0.9 1 7.97 96 
34 55 86 100 70 90 70 10 110 70 100 70 0.31 0.77 0.94 0.8 0.9 5 100 
35 50 84 120 80 100 70 20 120 80 110 70 0.33 0.9 0.94 0.99 1.13 8.77 110 
36 55 82 120 80 102 70 18 120 80 120 80 0.29 1.1 0.7 0.94 1.78 67.92 95 
37 48 80 130 80 110 70 20 130 80 130 80 0.34 1 0.87 0.7 0.8 10.08 94 
38 53 90 120 80 102 70 18 120 80 120 80 0.53 1.02 0.78 0.84 1.2 33.6 83 
39 52 84 116 70 90 70 26 120 80 120 80 0.55 0.9 1.08 0.9 1.21 6.08 102 
40 55 88 120 80 100 70 20 120 80 120 80 0.52 1.22 1.08 0.8 0.96 60.05 96 
 
AUTONOMIC FUNCTION TESTS FOR  GROUP A 
 
S.No Age PR 
Supine BP Orthostasis Ort. 
Var 
MAM 
 
CPT 
QTc 
Valsal 
Ra 
S:L 
Ra 
30:15 
Ra 
E:I    
Ra 
Estrogen 
pg/dl 
Bld 
sugar 
mgs/dl SBP DBP SBP DBP SBP DBP SBP DBP 
1 45 76 100 70 100 70 0 110 70 110 70 0.33 1.2 1 1 1.2 35.06 72 
2 48 82 110 70 110 70 0 118 70 120 70 0.32 1.26 0.8 1.1 1.22 7.56 93 
3 50 82 126 80 120 80 6 130 80 130 90 0.27 1.18 1.38 1 1.37 51.69 116 
4 51 72 100 70 100 70 0 110 70 110 80 0.49 1.2 1.06 1.06 1.25 102.06 106 
5 50 70 100 70 100 70 0 110 70 110 70 0.39 1.21 0.89 1.07 1.2 65.02 102 
6 46 78 100 70 100 70 0 110 70 110 80 0.33 1.22 1.2 1.11 1.26 116.08 98 
7 47 72 126 80 100 70 26 130 80 130 90 0.3 1.22 0.88 1.08 1.21 136.28 80 
8 45 84 100 90 100 80 0 110 70 110 70 0.31 1.22 1.2 1.07 1.28 96.02 102 
9 45 84 126 70 100 60 26 130 80 130 90 0.2 1.3 1.06 1.06 1.05 145.06 86 
10 49 90 110 70 110 70 0 120 70 120 70 0.3 1.03 1.02 0.82 1.03 186.03 84 
11 53 86 116 70 90 70 26 120 70 120 70 0.42 1.32 0.7 1.08 1.24 72.05 102 
12 50 74 116 80 110 70 6 120 80 120 80 0.28 1.1 108 1.08 1.22 104.06 106 
13 52 84 120 80 102 70 18 120 80 130 90 0.29 1.21 1.1 1.09 1.25 51.02 72 
14 51 88 112 80 110 80 2 120 90 120 80 0.3 1.25 0.8 1.1 1.3 192.05 100 
15 50 82 114 60 110 60 4 120 80 120 70 0.25 1.26 1.09 1.12 1.28 72 90 
16 48 84 120 80 90 70 30 120 90 120 80 0.4 1.08 1.1 1.1 1.25 106.06 88 
17 51 80 100 70 100 70 0 110 70 110 70 0.46 1.2 1.06 1.06 1.28 33.03 74 
 S.No 
 
 
Age 
 
 
PR 
 
Supine BP 
 
Orthostasis 
 
 
Ort. 
var 
      
     MAM 
 
 
CPT 
 
 
QTc 
 
 
Valsal 
Ra 
 
 
S:L 
Ra 
 
 
30:15 
Ra 
 
 
E:I    
Ra 
 
 
Estrogen 
pg/dl 
 
Bld 
sugar 
mgs/dl SBP DBP SBP DBP SBP DBP SBP DBP 
18 49 82 100 70 100 70 0 110 70 110 70 0.45 1.32 0.9 1.1 1.3 82.08 104 
19 53 88 130 80 100 70 30 130 80 130 80 0.38 1.26 1.02 1.1 1.3 51.03 84 
20 48 90 120 80 120 80 0 120 80 120 80 0.35 1.21 1.08 1.12 1.01 168 96 
21 52 92 130 80 130 80 0 130 80 130 80 0.29 1.12 1.1 1.08 1.28 96.04 106 
22 50 94 130 70 110 70 20 130 70 130 80 0.3 1.28 1.2 1.12 1.26 116.02 86 
23 49 88 130 80 130 80 0 130 80 130 90 0.5 1.1 1.04 1.1 1.24 164 76 
24 51 82 130 70 130 70 0 130 70 130 80 0.49 1.3 1.1 1.08 1.22 112 104 
25 46 76 120 80 120 80 0 130 70 130 80 0.32 1.26 1.06 1.2 1.3 72.05 96 
26 48 68 116 70 110 70 6 120 70 120 80 0.42 1.22 1.06 0.9 1.21 116.02 96 
27 51 82 100 70 100 70 0 110 70 110 70 0.5 1.26 1.04 1.1 1.02 76.05 130 
28 46 84 116 80 110 70 6 120 80 120 80 0.4 1.28 1.1 1.08 1.28 165.02 116 
29 49 86 120 80 90 70 30 120 80 120 80 0.37 1.24 0.9 1.06 1.3 26.05 104 
30 52 92 116 70 110 70 6 120 70 120 80 0.42 1.3 1.06 1.1 1.01 43.08 110 
31 53 94 120 80 90 70 30 120 80 120 80 0.4 1.28 1.04 1.14 1.26 141.02 120 
32 48 84 110 70 110 70 0 120 70 120 70 0.32 1.09 1.1 1.08 1.3 52.03 130 
33 51 70 116 70 110 70 6 120 70 120 80 0.33 1.21 1.02 1.1 1 68.04 110 
34 45 76 120 80 90 70 30 120 80 120 80 0.3 1.26 1.08 1.12 1.28 95.02 96 
35 50 78 110 70 110 70 0 116 70 120 80 0.31 1.3 1.18 0.8 1.3 162 84 
36 49 68 116 80 110 80 6 120 80 120 80 0.38 1.28 1.21 1.1 1.22 102 90 
37 53 70 110 70 110 70 0 110 70 110 70 0.4 1.24 1.1 1.08 1.26 32.05 100 
38 46 80 120 80 92 70 28 120 80 120 80 0.32 1.26 1.04 1 1.3 132.05 106 
39 52 92 110 80 110 80 0 110 80 110 80 0.3 1.3 1.1 1 1.28 78.02 120 
40 47 74 110 70 110 70 0 110 70 110 70 0.35 1.1 1.06 1.08 1.26 52.3 100 
 
